|
1
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman SL: Liver fibrosis-from bench to
bedside. J Hepatol. 1 Suppl 38:S38–S53. 2003. View Article : Google Scholar
|
|
3
|
Moreira RK: Hepatic stellate cells and
liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
|
|
4
|
Ellis EL and Mann DA: Clinical evidence
for the regression of liver fibrosis. J Hepatol. 56:1171–1180.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W and Qin C: General hallmarks of
microRNAs in brain evolution and development. RNA Biol. 12:701–708.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang XW, Heegaard NH and Orum H: MicroRNAs
in liver disease. Gastroenterology. 142:1431–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szabo G and Bala S: MicroRNAs in liver
disease. Nat Rev Gastroenterol Hepatol. 10:542–552. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Utaijaratrasmi P, Vaeteewoottacharn K,
Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N,
Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, et al: The
microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated
fibroblasts promotes migration of cancer cells. Mol Cancer.
17:102018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Howell LS, Ireland L, Park BK and Goldring
CE: MiR-122 and other microRNAs as potential circulating biomarkers
of drug-induced liver injury. Expert Rev Mol Diagn. 18:47–54. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He X, Sun Y, Lei N, Fan X, Zhang C, Wang
Y, Zheng K, Zhang D and Pan W: MicroRNA-351 promotes
schistosomiasis-induced hepatic fibrosis by targeting the vitamin D
receptor. Proc Natl Acad Sci USA. 115:180–185. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Liu J, Ma Y, Wang J, Zhu J, Liu J
and Zhang J: Integrated profiling of long non-coding RNAs and mRNAs
identifies novel regulators associated with liver fibrosis. Pathol
Res Pract. 214:1794–1803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aken BL, Achuthan P, Akanni W, Amode MR,
Bernsdorff F, Bhai J, Billis K, Carvalho-Silva D, Cummins C,
Clapham P, et al: Ensembl 2017. Nucleic Acids Res. 45:D635–d642.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vuppalanchi R, Liang T, Goswami CP,
Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC and
Chalasani N: Relationship between differential hepatic microRNA
expression and decreased hepatic cytochrome P450 3A activity in
cirrhosis. Plos One. 8:e744712013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Diaz G, Melis M, Tice A, Kleiner DE,
Mishra L, Zamboni F and Farci P: Identification of microRNAs
specifically expressed in hepatitis C virus-associated
hepatocellular carcinoma. Int J Cancer. 133:816–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Britton RS and Bacon BR: Intracellular
signaling pathways in stellate cell activation. Alcohol Clin Exp
Res. 23:922–925. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao XK, Yu L, Cheng ML, Che P, Lu YY,
Zhang Q, Mu M, Li H, Zhu LL, Zhu JJ, et al: Focal adhesion kinase
regulates hepatic stellate cell activation and liver fibrosis. Sci
Rep. 7:40322017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Ma J, Chen L, Xie XL and Jiang H:
Inhibition of focal adhesion kinase on hepatic stellate-cell
adhesion and migration. Am J Med Sci. 353:41–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsuchida T and Friedman SL: Mechanisms of
hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol.
14:397–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gantier MP, McCoy CE, Rusinova I, Saulep
D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F and
Williams BR: Analysis of microRNA turnover in mammalian cells
following Dicer1 ablation. Nucleic Acids Res. 39:5692–5703. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee HM, Nguyen DT and Lu LF: Progress and
challenge of microRNA research in immunity. Front Genet. 5:1782014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shenoy A and Blelloch RH: Regulation of
microRNA function in somatic stem cell proliferation and
differentiation. Nat Rev Mol Cell Biol. 15:565–576. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Anthony PP, Ishak KG, Nayak NC, Poulsen
HE, Scheuer PJ and Sobin LH: The morphology of cirrhosis.
Recommendations on definition, nomenclature, and classification by
a working group sponsored by the World Health Organization. J Clin
Pathol. 31:395–414. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang CY, Yuan WG, He P, Lei JH and Wang
CX: Liver fibrosis and hepatic stellate cells: Etiology,
pathological hallmarks and therapeutic targets. World J
Gastroenterol. 22:10512–10522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li D, He L, Guo H, Chen H and Shan H:
Targeting activated hepatic stellate cells (aHSCs) for liver
fibrosis imaging. EJNMMI Res. 5:712015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Trautwein C, Friedman SL, Schuppan D and
Pinzani M: Hepatic fibrosis: Concept to treatment. J Hepatol. 62
Suppl 1:S15–S24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mallat A and Lotersztajn S: Reversion of
hepatic stellate cell to a quiescent phenotype: From myth to
reality? J Hepatol. 59:383–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hattori S, Dhar DK, Hara N, Tonomoto Y,
Onoda T, Ono T, Yamanoi A, Tachibana M, Tsuchiya M and Nagasue N:
FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect
on liver cirrhosis through downregulation of Runx2. Lab Invest.
87:591–601. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Furukawa F, Matsuzaki K, Mori S, Tahashi
Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki
Y, et al: p38 MAPK mediates fibrogenic signal through Smad3
phosphorylation in rat myofibroblasts. Hepatology. 38:879–889.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fernandez-Ramos D, Fernandez-Tussy P,
Lopitz-Otsoa F, Gutiérrez-de-Juan V, Navasa N, Barbier-Torres L,
Zubiete-Franco I, Simón J, Fernández AF, Arbelaiz A, et al:
MiR-873-5p acts as an epigenetic regulator in early stages of liver
fibrosis and cirrhosis. Cell Death Dis. 9:9582018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou L, Liu S, Han M, Ma Y, Feng S, Zhao
J, Lu H, Yuan X and Cheng J: miR-185 inhibits fibrogenic activation
of hepatic stellate cells and prevents liver fibrosis. Mol Ther
Nucleic Acids. 10:91–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tao L, Xue D, Shen D, Ma W, Zhang J, Wang
X, Zhang W, Wu L, Pan K, Yang Y, et al: MicroRNA-942 mediates
hepatic stellate cell activation by regulating BAMBI expression in
human liver fibrosis. Arch Toxicol. 92:2935–2946. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hyun J, Park J, Wang S, Kim J, Lee HH, Seo
YS and Jung Y: MicroRNA expression profiling in CCl(4)-induced
liver fibrosis of Mus musculus. Int J Mol Sci. 17:E9612016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen W, Zhao W, Yang A, Xu A, Wang H, Cong
M, Liu T, Wang P and You H: Integrated analysis of microRNA and
gene expression profiles reveals a functional regulatory module
associated with liver fibrosis. Gene. 636:87–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Murakami Y, Toyoda H, Tanaka M, Kuroda M,
Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T and Shimotohno K:
The progression of liver fibrosis is related with overexpression of
the miR-199 and 200 families. PloS One. 6:e160812011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu J, Zhang Z, Zhang Y, Li W, Zheng W, Yu
J, Wang B, Chen L, Zhuo Q, Chen L, et al: MicroRNA-212 activates
hepatic stellate cells and promotes liver fibrosis via targeting
SMAD7. Biochem Biophys Res Commun. 496:176–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
